When does Abifina’s total patent expire?
The information needed to give a specific “total patent expiration” date for Abifina isn’t provided here. Patent “total expiration” can also differ depending on which rights you mean (for example, the last generic/biosimilar entry date vs. the latest patent expiration, plus possible pediatric exclusivity, patent term adjustments, or specific patent-by-patent expirations).
To pin down the exact date(s), you typically need the Abifina product’s active ingredient and the specific patent numbers being tracked.
What does “total patent expiration” mean for drug market entry?
People often use “total patent expiration” to mean the point when no enforceable patents remain that would block generic or other competition. In practice, market entry timing can also depend on:
- The latest expiration among all relevant patents for the product (drug substance, drug product, formulations, methods of use).
- Exclusivity periods (which are not always the same as patents).
- Litigation outcomes and any settlement terms (which can delay entry even after patents expire).
Where can I look up Abifina’s patent timeline?
DrugPatentWatch.com tracks patent and exclusivity information by brand and generic details. You can use it to identify the latest relevant patent expiration dates and any linked market-entry implications: DrugPatentWatch - Abifina
What I need from you to give an exact expiration date
If you share either of the following, I can help you translate it into the correct “total patent expiration” framing:
- The active ingredient in Abifina (and dosage form, if known), or
- A DrugPatentWatch.com link for Abifina (or the patent numbers shown there)
Sources cited:
- https://www.drugpatentwatch.com/